|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-1-15
|
|
pubmed:abstractText |
To clarify the effect of bevacizumab on NK012 therapy in mice bearing U87MG glioblastoma orthotopic xenografts in comparison with the combination therapy of irinotecan hydrochloride (CPT-11) with bevacizumab.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin,
http://linkedlifedata.com/resource/pubmed/chemical/Micelles,
http://linkedlifedata.com/resource/pubmed/chemical/Polymers,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
521-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20068081-Angiogenesis Inhibitors,
pubmed-meshheading:20068081-Animals,
pubmed-meshheading:20068081-Antibodies, Monoclonal,
pubmed-meshheading:20068081-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:20068081-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20068081-Brain Neoplasms,
pubmed-meshheading:20068081-Camptothecin,
pubmed-meshheading:20068081-Cell Line, Tumor,
pubmed-meshheading:20068081-Dose-Response Relationship, Drug,
pubmed-meshheading:20068081-Female,
pubmed-meshheading:20068081-Glioblastoma,
pubmed-meshheading:20068081-Humans,
pubmed-meshheading:20068081-Mice,
pubmed-meshheading:20068081-Mice, Inbred BALB C,
pubmed-meshheading:20068081-Mice, Nude,
pubmed-meshheading:20068081-Micelles,
pubmed-meshheading:20068081-Polymers,
pubmed-meshheading:20068081-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Antitumor effect of NK012, a 7-ethyl-10-hydroxycamptothecin-incorporating polymeric micelle, on U87MG orthotopic glioblastoma in mice compared with irinotecan hydrochloride in combination with bevacizumab.
|
|
pubmed:affiliation |
Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwanoha, Kashiwa, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
